135 related articles for article (PubMed ID: 7819105)
1. Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP.
Cattaneo M; Zighetti ML; Lombardi R; Mannucci PM
Br J Haematol; 1994 Dec; 88(4):826-9. PubMed ID: 7819105
[TBL] [Abstract][Full Text] [Related]
2. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
[TBL] [Abstract][Full Text] [Related]
3. Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine.
Cattaneo M; Lombardi R; Bettega D; Lecchi A; Mannucci PM
Arterioscler Thromb; 1993 Mar; 13(3):393-7. PubMed ID: 8443143
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
[TBL] [Abstract][Full Text] [Related]
5. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
6. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
[TBL] [Abstract][Full Text] [Related]
7. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP.
Oda A; Yokoyama K; Murata M; Tokuhira M; Nakamura K; Handa M; Watanabe K; Ikeda Y
Thromb Haemost; 1995 Aug; 74(2):736-42. PubMed ID: 8585015
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
[TBL] [Abstract][Full Text] [Related]
10. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
[TBL] [Abstract][Full Text] [Related]
11. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willbrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets.
Wang JS
Eur J Appl Physiol; 2004 May; 91(5-6):741-7. PubMed ID: 14872251
[TBL] [Abstract][Full Text] [Related]
12. DDAVP's shortening of the bleeding time seems due to plasma von Willebrand factor.
Beck KH; Bleckmann U; Mohr P; Kretschmer V
Semin Thromb Hemost; 1995; 21 Suppl 2():40-3. PubMed ID: 7660156
[TBL] [Abstract][Full Text] [Related]
13. Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.
Pfueller SL; Howard MA; White JG; Menon C; Berry EW
Thromb Haemost; 1987 Dec; 58(4):1060-3. PubMed ID: 3502198
[TBL] [Abstract][Full Text] [Related]
14. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
16. DDAVP-induced enhancement of platelet retention: its dependence on platelet-von Willebrand factor and the platelet receptor GP IIb/IIIa.
Lethagen S; Nilsson IM
Eur J Haematol; 1992 Jul; 49(1):7-13. PubMed ID: 1499698
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI
Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo effects of desmopressin on platelet function.
Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
Yang X; Disa J; Rao AK
Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
[TBL] [Abstract][Full Text] [Related]
20. Use of DDAVP in inherited and acquired platelet dysfunction.
DiMichele DM; Hathaway WE
Am J Hematol; 1990 Jan; 33(1):39-45. PubMed ID: 2293761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
